Afecta Pharmaceuticals, Inc.
Records under this name other than patents Afecta Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Afecta Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,130,729 | CCL2 inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,858,876 | CCL2 inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,940,132 | CCL5 inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,318,111 | CCL5 inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 6,897,212 | Treatment of Oppositional Defiant Disorder and Conduct Disorder with 5-Aminoalkyl-4,5,6,7-Tetrahydro-4-Oxyindolones Term ended Term ended Apr 19, 2022 · High confidence | Term ended | Term ended Apr 19, 2022 | High confidence |